• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Page Path

5
results for

"Ki-Sook Hong"

Filter

Article category

Keywords

Publication year

Authors

"Ki-Sook Hong"

Original Articles

[English]
Application of Six Sigma Metrics to Improve Quality Control for Point-of-care Glucose Testing
Sholhui Park, Wookeun Lee, Tae-Dong Jeong, Hae-Sun Chung, Ki-Sook Hong
Ewha Med J 2020;43(3):43-48.   Published online July 31, 2020
DOI: https://doi.org/10.12771/emj.2020.43.3.43
Objectives

Six sigma is a quality management system for the assessment of precision and accuracy. We aim to apply the six sigma rule to quality control (QC) of point-of-care (POC) glucose meters in a tertiary hospital.

Methods

Thirty POC glucose meters installed at Ewha Womans University Mokdong Hospital were monitored between January 2013 and March 2014. The QC data from the POC glucose meters at low and high levels were collected. The monthly mean, standard deviation, bias, coefficient of variation, and mean sigma metrics were calculated. The correlation between accuracy and precision was assessed based on the percentage bias and coefficient of variation. Comprehensive instructions on the QC and maintenance of the devices were provided in the departments with poor sigma scores. A follow-up assessment was performed after the intervention.

Results

The mean sigma values for the low and high controls were 3.29 and 3.71, respectively. At the low and high controls, 36.6% and 10% of the glucose meters showed a sigma value <3. The causes of low sigma values included the use of expired control materials, prolonged air exposure of the sample strip, lack of user training, and errors in device maintenance. On follow-up monitoring for 3 months following QC intervention, 23.3% (low control) and 6.6% (high control) of the glucose meters scored a sigma value <3, indicating improved QC.

Conclusion

Sigma metrics-based QC can successfully improve accuracy and precision of POC glucose meters in an objective and quantitative manner and can be used for follow up after QC intervention.

Citations

Citations to this article as recorded by  
  • Analysis of hematology quality control using six sigma metrics
    Shreya Goel, Amit R. Nisal, Ankita Raj, Ravindra C. Nimbargi
    Indian Journal of Pathology and Microbiology.2024; 67(2): 332.     CrossRef
  • Potential use of Six Sigma metrics in the quality control review of hospital glucose meters
    Yun Huang, Callie Loveday, Anne Vincent
    Heliyon.2024; 10(17): e36651.     CrossRef
  • Development of a Systematic Quality Control Program for Point-of-Care Glucose Testing
    Yong Hun Jo, Sooin Choi, Jae Joon Lee, Jeong Gwon Kim, Yong-Wha Lee
    Journal of Laboratory Medicine and Quality Assurance.2023; 45(3): 107.     CrossRef
  • 152 View
  • 0 Download
  • 2 Web of Science
  • 3 Crossref
[English]
Polymorphism of M341I in the Type A Human Natriuretic Peptide Receptor Gene in Essential Hypertension in Korea
Sung Eun Cho, Ki-Sook Hong, Young-Dae Kim
Ewha Med J 2012;35(2):95-101.   Published online September 30, 2012
DOI: https://doi.org/10.12771/emj.2012.35.2.95
Objectives

There are 3 subtypes of natriuretic peptide (NP) receptors: type A natriuretic peptide receptor (NPRA), NPRB, and NPRC. The NPRA gene polymorphism, consisting of substition of methionine (ATG) to isoleucine (ATC) at nucleotide 1023 (M341I) of exon 3 was revealed to be associated with increased risk for essential hypertension (EH) in Japanese people. The purpose of this study is to investigate association between EH and the M341I polymorphism in the NPRA gene in Korea.

Methods

Eighty patients in whom type B natriuretic peptide (BNP) was measured were enrolled in this study. 66 patients had EH and 14 patients did not. The polymorphism of M341I was evaluated by multiplex genotyping polymerase chain reaction and by sequencing analysis.

Results

The overall distribution of alleles was not significantly different between the control and EH groups. However, the C/C homozygous genotype was found only in the EH group. In the EH group, patient carrying the C/C homozygous genotype had the trend of having higher systolic and diastolic BP levels regardless of the previous treatment, even though other laboratory markers including BNP levels had no significant differences according to the genotypes.

Conclusion

This would be meaningful for the first identification of the M341I polymorphism in the NPRA gene and for the first suggestion of association of the EH with it in Korea.

  • 70 View
  • 0 Download

Review Article

[English]
Review of Molecular Markers for Thyroid Cancer
Jae-Joon Han, Ki-Sook Hong
Ewha Med J 2012;35(1):3-10.   Published online March 31, 2012
DOI: https://doi.org/10.12771/emj.2012.35.1.3

The incidence of thyroid cancer has been rapidly increased in Korea. Although fine needle aspiration cytology is recommended for diagnosis of cancer, there are some limitations. Patients with indeterminate or suspicious cytology category in which malignancy cannot be ruled out usually undergone a thyroidectomy, however, only 10~25% of them finally diagnosed as cancer. According to the progress in understanding molecular mechanism, some mutations or other molecular alterations have been studied for the diagnostic and prognostic markers for thyroid cancer. The majority of papillary thyroid cancers have BRAF and RAS mutations or RET/PTC rearrangement, and approximately 80% of follicular thyroid cancers harbor a RAS mutation or PAX8/PPARγ rearrangement. These genetic alterations are mostly studied and current clinical guidelines suggested that these molecular markers may help management for patients with indeterminate cytology. In addition, recent studies demonstrated the high sensitivity and specificity of thyroid-stimulating hormone receptor mRNA in diagnosing cancer in patients with indeterminate cytology. For the detection of recurrent or residual thyroid cancer, serum thyroglobulin is the only circulating marker in clinical practice. However, it lacks sensitivity and is unreliable specifically in the presence of antibodies to thyroglobulin. Recent studies demonstrated a significant role of measuring the mRNA of thyroglobulin, thyroid peroxidase, thyroid-stimulating hormone receptor, and sodium/iodine symporter in peripheral blood for monitoring of the recurrence of thyroid cancer.

  • 78 View
  • 0 Download

Original Article

[English]
Apolipoprotein B/A1 Ratio as Risk Factor for Cerebral Ischemic Stroke
Chorong Hahm, Ki-Sook Hong
Ewha Med J 2012;35(1):21-25.   Published online March 31, 2012
DOI: https://doi.org/10.12771/emj.2012.35.1.21
Objectives

According to current knowledge, apolipoprotein B/A1 (apoB/A1) ratio is like to be risk factor in coronary artery disease. There is evidence form case-control studies that apoB/A1 ratio may be a superior to LDL and HDL cholesterol in discriminating coronary artery disease case subject from control subject. However, relationship between apoB/A1 ratio and cerebral ischemic stroke is undefined. The main object of this study is to determine whether the risk of cerebral ischemic stroke is related to levels of apoB/A1.

Methods

The study group included 643 patients (Men, 372; Women, 271) who diagnosed cerebral ischemic stroke between January 2008 to December 2010. The control groups were composed of 378 patients (Men, 139; Women, 239) who diagnosed other neurological disease. The correlation between lipid profiles and odds ratio of 10 preliminary risk factors (total cholesterol, triglyceride, LDL, HDL, apoA1, apoB, apoB/A1 ratio, non HDL, total cholesterol/HDL ratio, LDL/HDL ratio) for stroke were analyzed.

Results

ApoB/A1 ratio was significantly increased in case patients compared with control subjects. Multivariate logistic regression analysis identified decrease of apoB/A1 ratio (odds ratio [OR], 1.583; 95% confidence intercal [CI], 1.105~2.269) as significantly associated with stroke. Individual apoA1 (OR, 1.303; 95% CI, 0.967~1.755) and apoB (OR, 1.397; 95% CI, 0.773~2.523) were also not significantly associated with cerebral ischemic stroke.

Conclusion

Increase of apoB/A1 ratio is associated with an increase risk of cerebral ischemic stroke. Use of apoB/A1 ratio is efficient as conventional lipids, for the identification of subjects at increased risk of stroke. So apoB/A1 ratio to standard lipid profile testing could improve the evaluation of risk factors of cerebral ischemic stroke.

Citations

Citations to this article as recorded by  
  • Clinical Research Progress of Apolipoprotein B/Apolipoprotein A1
    小红 李
    Advances in Clinical Medicine.2025; 15(03): 253.     CrossRef
  • 98 View
  • 0 Download
  • 1 Crossref
Editorial
[English]
English or Korean?
Ryung-Ah Lee, Ki-Sook Hong
Ewha Med J 2012;35(1):1-2.   Published online March 31, 2012
DOI: https://doi.org/10.12771/emj.2012.35.1.1

Citations

Citations to this article as recorded by  
  • How Can College Journal Survive Beyond the Dispute on the Language of Journal?
    Sun Huh
    The Ewha Medical Journal.2012; 35(2): 73.     CrossRef
  • 93 View
  • 1 Download
  • 1 Crossref
TOP